Clinical Trial - Trial jRCT2031220471
Access comprehensive clinical trial information for jRCT2031220471 through Pure Global AI's free database. This phase not specified trial is sponsored by Eli Lilly Japan K.K. and is currently Recruiting. The study focuses on Alzheimer's Disease.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Japan Registry Clinical Trial data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
jRCT2031220471
Recruiting
Trial Details
Japan Registry Clinical Trial • jRCT2031220471
Untitled Trial
Assessment of Safety, Tolerability, and Efficacy Measured by Amyloid Reduction of LY3372993 in Early Symptomatic Alzheimer's Disease (J1G MC LAKC)
Study Focus
Interventional
Sponsor & Location
Eli Lilly Japan K.K.
United States of America
Timeline & Enrollment
N/A
N/A
N/A
ICD-10 Classifications
Alzheimer disease
Alzheimer disease, unspecified
Other Alzheimer disease
Dementia in Alzheimer disease
Dementia in Alzheimer disease, unspecified
Data Source
Japan Registry Clinical Trial
jRCT2031220471
Non-Device Trial